Holen Sie sich die Stockscreener-App
12.69
3.57%
-0.47
Handel nachbörslich:
12.44
-0.25
-1.97%
Schlusskurs vom Vortag:
$13.16
Offen:
$13.06
24-Stunden-Volumen:
1.21M
Relative Volume:
1.01
Marktkapitalisierung:
$1.23B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-137.25M
KGV:
-6.7143
EPS:
-1.89
Netto-Cashflow:
$-121.97M
1W Leistung:
-5.30%
1M Leistung:
+9.73%
6M Leistung:
+123.81%
1J Leistung:
+34.86%
1-Tages-Spanne:
$12.26
$13.42
1-Wochen-Bereich:
$12.26
$13.81
52-Wochen-Spanne:
$3.8951
$14.93
Oric Pharmaceuticals Inc Stock (ORIC) Company Profile
Firmenname
Oric Pharmaceuticals Inc
Sektor
Branche
Telefon
(650) 388-5600
Adresse
240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA
Vergleichen Sie ORIC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORIC
Oric Pharmaceuticals Inc
|
12.69 | 1.28B | 0 | -137.25M | -121.97M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Fortgesetzt | Guggenheim | Buy |
| 2025-07-08 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2024-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2024-09-06 | Eingeleitet | Stifel | Buy |
| 2024-02-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-09-22 | Eingeleitet | Wedbush | Outperform |
| 2023-03-23 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-03-21 | Hochstufung | Guggenheim | Neutral → Buy |
| 2023-03-16 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Perform |
| 2022-04-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-03-25 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-03-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-22 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-03-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-07-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-01-25 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-08-13 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-08-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-19 | Eingeleitet | Citigroup | Neutral |
| 2020-05-19 | Eingeleitet | Guggenheim | Buy |
| 2020-05-19 | Eingeleitet | JP Morgan | Overweight |
| 2020-05-19 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Oric Pharmaceuticals Inc Aktie (ORIC) Neueste Nachrichten
ORIC Pharmaceuticals Inc. stock chart pattern explained2025 Sector Review & Fast Exit/Entry Strategy Plans - newser.com
Multi factor analysis applied to ORIC Pharmaceuticals Inc.Quarterly Earnings Report & Risk Managed Investment Strategies - newser.com
Sentiment analysis tools applied to ORIC Pharmaceuticals Inc.July 2025 Chart Watch & Weekly Watchlist for Hot Stocks - newser.com
Is ORIC Pharmaceuticals Inc. (4TZ) stock positioned for secular growthPortfolio Return Summary & Capital Protection Trade Alerts - newser.com
What dividend safety score for ORIC Pharmaceuticals Inc. stockOptions Play & Real-Time Market Sentiment Alerts - newser.com
Will ORIC Pharmaceuticals Inc. stock maintain momentum in 2025Weekly Market Outlook & Accurate Technical Buy Alerts - newser.com
Sector ETF performance correlation with ORIC Pharmaceuticals Inc.Weekly Trade Report & Precise Swing Trade Entry Alerts - newser.com
Why ORIC Pharmaceuticals Inc. (4TZ) stock attracts HNW investorsGap Up & High Accuracy Investment Entry Signals - newser.com
Why analysts recommend ORIC Pharmaceuticals Inc. (4TZ) stockJuly 2025 Recap & Safe Capital Investment Plans - newser.com
Has ORIC Pharmaceuticals Inc. found a price floor2025 Market WrapUp & Risk Controlled Daily Plans - newser.com
Why ORIC Pharmaceuticals Inc. (4TZ) stock benefits from AI revolutionRisk Management & Technical Pattern Alert System - newser.com
AlphaQuest LLC Lowers Holdings in Oric Pharmaceuticals, Inc. $ORIC - MarketBeat
Can you recover from losses in ORIC Pharmaceuticals Inc.2025 Buyback Activity & Reliable Entry Point Alerts - newser.com
What to expect from ORIC Pharmaceuticals Inc. in the next 30 daysWeekly Volume Report & Daily Profit Focused Screening - newser.com
Is ORIC Pharmaceuticals Inc. stock attractive after correctionJuly 2025 Levels & Real-Time Stock Entry Alerts - newser.com
Is this a good reentry point in ORIC Pharmaceuticals Inc.Market Volume Summary & AI Driven Stock Movement Reports - newser.com
Published on: 2025-11-02 03:17:27 - newser.com
Why ORIC Pharmaceuticals Inc. (4TZ) stock stays on top picksJuly 2025 Action & High Accuracy Swing Entry Alerts - newser.com
Relative strength of ORIC Pharmaceuticals Inc. in sector analysisJuly 2025 Drop Watch & Long-Term Safe Return Strategies - newser.com
How to read the order book for ORIC Pharmaceuticals Inc.2025 Earnings Surprises & Verified Technical Trade Signals - newser.com
D pipelineBull Run & Technical Confirmation Trade Alerts - newser.com
What technical models suggest about ORIC Pharmaceuticals Inc.’s comebackDividend Hike & AI Forecast for Swing Trade Picks - newser.com
Will ORIC Pharmaceuticals Inc. stock split again soonJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
Wedbush Reiterates "Outperform" Rating for Oric Pharmaceuticals (NASDAQ:ORIC) - MarketBeat
Finanzdaten der Oric Pharmaceuticals Inc-Aktie (ORIC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):